Infections in patients with inflammatory bowel disease receiving anti-tumor necrosis factor agents are not associated with higher serum drug levels

被引：0
|
作者：
Chu, I. E. [1 ,2 ]
Su, H. Y. [1 ,2 ]
Martin, C. [3 ]
Sparrow, M. P. [1 ,2 ]
机构：
[1] Alfred Hosp, Alfred Hlth, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [31] Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents
    Eickstaedt, Joshua B.
    Killpack, Luke
    Tung, Jeanne
    Davis, Dawn
    Hand, Jennifer L.
    Tollefson, Megha M.
    PEDIATRIC DERMATOLOGY, 2017, 34 (03) : 253 - 260
  • [32] Efficacy of iron supplementation in patients with inflammatory bowel disease treated with anti-tumor necrosis factor-alpha agents
    Kim, Su Young
    An, Sejin
    Park, Dong Kyun
    Kwon, Kwang An
    Kim, Kyoung Oh
    Chung, Jun-Won
    Kim, Jung Ho
    Kim, Yoon Jae
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2020, 13
  • [33] Immunological relationship between Helicobacter pylori and anti-tumor necrosis factor α agents in inflammatory bowel disease
    Huang, Han
    Gan, Chenxiao
    Cai, Yan
    Wu, Lingkang
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 49 (01) : 70 - 76
  • [34] Utility of serum anti-tumor necrosis factor levels and biomarkers in predicting endoscopic disease activity and clinical remission in inflammatory bowel disease
    Tan, J.
    Neeman, T.
    Subramaniam, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 145 - 145
  • [35] Should patients with inflammatory bowel disease and depression be given anti-tumor necrosis factor therapy?
    Barnes, A.
    Mountifield, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 130 - 130
  • [36] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Androulakis, Ioannis
    Zavos, Christos
    Christopoulos, Panagiotis
    Mastorakos, George
    Gazouli, Maria
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (47) : 13205 - 13211
  • [37] Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease
    Peter, Inga
    Dubinsky, Marla
    Bressman, Susan
    Park, Andrew
    Lu, Changyue
    Chen, Naijun
    Wang, Anthony
    JAMA NEUROLOGY, 2018, 75 (08) : 939 - 946
  • [38] Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease
    Ioannis Androulakis
    Christos Zavos
    Panagiotis Christopoulos
    George Mastorakos
    Maria Gazouli
    World Journal of Gastroenterology, 2015, 21 (47) : 13205 - 13211
  • [39] Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
    Bortlik, Martin
    Duricova, Dana
    Machkova, Nadezda
    Hruba, Veronika
    Lukas, Martin
    Mitrova, Katarina
    Romanko, Igor
    Bina, Vladislav
    Malickova, Karin
    Kolar, Martin
    Lukas, Milan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (02) : 196 - 202
  • [40] Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease
    Fernandes, Carlos
    Allocca, Mariangela
    Danese, Silvio
    Fiorino, Gionata
    IMMUNOTHERAPY, 2015, 7 (02) : 175 - 190
12345